Buscar
-
Genomic analysis of primary and secondary myelofibrosis redefines the prognostic impact of ASXL1 mutations: a FIM study.
(Blood Advances. vol. 5, n° 5, pp. 1442-1451, 2021-03-09)Article de revue -
Immunization against α β and α β in Glanzmann thrombasthenia patients carrying the French Gypsy mutation.
(Journal of Thrombosis and Haemostasis. vol. 19, n° 1, pp. 255-261, 2021-01-01)Article de revue -
Clonal haematopoiesis and cardiovascular diseases: A growing relationship
(Archives of cardiovascular diseases, 2021-03-10)Article de revueLibre acceso -
Mast Cells Are the Trigger of Small Vessel Disease and Diastolic Dysfunction in Diabetic Obese Mice.
(Arteriosclerosis, Thrombosis, and Vascular Biology. vol. 41, n° 4, pp. e193-e207, 2021-04-01)Article de revueLibre acceso -
History of lower-limb complications and risk of cancer death in people with type 2 diabetes.
(Cardiovascular Diabetology. vol. 20, n° 1, pp. 3, 2021-01-04)Article de revueLibre acceso -
Lung cancer and diabetes: A role for advanced glycation end-products?
(European Journal of Clinical Investigation. vol. 51, n° 1, pp. e13389, 2021-01-01)Article de revue -
Subcutaneous Antibiotic Therapy: The Why, How, Which Drugs and When
(Journal of the American Medical Directors Association. vol. 22, n° 1, pp. 50-55.e6, 2021-01-01)Article de revueLibre acceso